Open AccessUtilidad clínica del iloprost inhalado en la hipertensión arterial pulmonar
Author(s) -
Luis E. Santos-Martínez,
Luis Antonio Moreno-Ruíz,
Moisés JiménezSantos,
Sergio G. Olmos-Temois,
Luis Armando Bojorquez-Guerrero,
Francisco M. Baranda-Tovar
Publication year - 2014
Publication title -
archivos de cardiología de méxico
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.149
H-Index - 17
eISSN - 1405-9940
pISSN - 1665-1731
DOI - 10.1016/j.acmx.2014.01.003
Subject(s) - iloprost , medicine , drug , cardiology , prostacyclin , pharmacology
Inhaled iloprost is a drug from the group of prostacyclins used in the treatment of pulmonary arterial hypertension. Its efficacy and safety have allowed its use as monotherapy and combination therapy. This review describes the product characteristics, amenable to treatment groups, and updated clinical evidence of drug use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom